Cancer Therapeutic with Increased Efficacy and Reduced Side Effects
PDK Inhibitor Compounds and Methods of Use Thereof
None
Inventor: Charlier, Jr., Henry A. | Gerasimchuk, Nikolay
Priority Number: US7727967B2
IPC Current: A61K003170 | A01N003324 | A01N004304 | A61K003115
US Class: 514034 | 514640
Assignee Applicant: Boise State University,Boise
Title: Cyanooxime inhibitors of carbonyl reductase and methods of using said inhibitors in treatments involving anthracyclines
Usefulness: Cyanooxime inhibitors of carbonyl reductase and methods of using said inhibitors in treatments involving anthracyclines
Summary: For improving efficacy of anthracycline cancer treatment (claimed).
Novelty: Pharmaceutical composition for improving efficacy of anthracycline cancer treatment comprises anthracycline compounds and enzyme inhibitors comprising halogenated aryl group
诊断/治疗
癌症/肿瘤
Jul 1, 2011
8,492,344
美国
